文献速递瓣膜病与结构性心脏病血脂与心血管预防

家族性高胆固醇血症患者主动脉瓣置换需求预测因素

Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
PubMed 文献 · Eur Heart J · 2021-01-01

AIMS: Familial hypercholesterolaemia (FH) and elevated lipoprotein(a) [Lp(a)] are inherited disorders associated with premature atherosclerotic cardiovascular disease (ASCVD).…

要点

  • FH患者因主动脉瓣狭窄需AVR的风险是未患病亲属的5.71倍(95%CI 1.78-18.4)。
  • 高龄、既往ASCVD、高血压、LDL-C与Lp(a)累积暴露年限增加及Lp(a)升高独立预测AVR需求。
  • 降低LDL-C与Lp(a)并控制高血压或可延缓AVS进展,但需临床试验验证。

核心结论

  • FH患者因AVS需AVR的风险显著增加,尤其合并高龄、既往ASCVD、高血压、LDL-C与Lp(a)累积暴露年限增加及Lp(a)升高者。

研究设计与样本

  • SAFEHEART为长期前瞻性队列研究,纳入3712例分子确诊FH患者和1310例未患病亲属,平均随访7.48年。

主要发现

  • FH患者AVR发生率显著更高(log-rank 5.93,P=0.015)。
  • Cox回归显示FH与AVR相关(HR 3.89,95%CI 1.20-12.63,P=0.024)。

关键数值与推荐

  • AVR需求独立预测因素包括:高龄、既往ASCVD、高血压、LDL-C与Lp(a)累积暴露年限增加、Lp(a)升高。

临床怎么用

  • 对FH患者应评估主动脉瓣狭窄风险,尤其关注高龄、既往ASCVD、高血压及Lp(a)升高者。
  • 降低LDL-C与Lp(a)并控制高血压可能延缓AVS进展,但需临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Familial hypercholesterolaemia (FH) and elevated lipoprotein(a) [Lp(a)] are inherited disorders associated with premature atherosclerotic cardiovascular disease (ASCVD). Aortic valve stenosis (AVS) is the most prevalent valvular heart disease and low-density lipoprotein cholesterol (LDL-C) and Lp(a) may be involved in its pathobiology. We investigated the frequency and predictors of severe AVS requiring aortic valve replacement (AVR) in molecularly defined patients with FH. METHODS AND RESULTS: SAFEHEART is a long-term prospective cohort study of a population with FH and non-affected relatives (NAR). We analysed the frequency and predictors of the need for AVR due to AVS in this cohort. Five thousand and twenty-two subjects were enrolled (3712 with FH; 1310 NAR). Fifty patients with FH (1.48%) and 3 NAR (0.27%) required AVR [odds ratio 5.71; 95% confidence interval (CI): 1.78-18.4; P = 0.003] after a mean follow-up of 7.48 (3.75) years. The incidence of AVR was significantly higher in patients with FH (log-rank 5.93; P = 0.015). Cox regression analysis demonstrated an association between FH and AVR (hazard ratio: 3.89; 95% CI: 1.20-12.63; P = 0.024), with older age, previous ASCVD, hypertension, increased LDL-CLp(a)-years, and elevated Lp(a) being independently predictive of an event. CONCLUSION: The need for AVR due to AVS is significantly increased in FH patients, particularly in those who are older and have previous ASCVD, hypertension, increased LDL-CLp(a)-years and elevated Lp(a). Reduction in LDL-C and Lp(a) together with control of hypertension could retard the progression of AVS in FH, but this needs testing in clinical trials.ClinicalTrials.gov number NCT02693548.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Pérez de Isla L, Watts GF, Alonso R, et al. Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia. Eur Heart J. 2021. PMID: 33437997. doi:10.1093/eurheartj/ehaa1066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。